UCH Ibadan Partners with Medbury Pharmaceutical to Enhance Patient Care

UCH Ibadan Partners with Medbury Pharmaceutical to Enhance Patient Care

UCH Ibadan Partners with Medbury Pharmaceutical to Enhance Patient Care

The University College Hospital (UCH) has officially launched a Public-Private Partnership with Medbury Pharmaceutical, a division of the Medbury Healthcare Group.

The partnership, inaugurated on September 16, 2025, aims to improve patient care and ensure the consistent availability of essential medications.

READ ALSO: BUK Mourns Loss of Two Promising Students

The partnership underscores the hospital's commitment to patient care and welfare, with the Chief Medical Director, Prof. Jesse Abiodun Otegbayo, emphasizing the administration's focus on patient-centered care.

RECOMMENDED FOR YOU: Kwara State University Community Extends Birthday Felicitations to Pro‑Chancellor Professor Abdulganiyu Ambali

The partnership is expected to deliver positive outcomes for patients and contribute meaningfully to the well-being of humanity. The hospital's management and Medbury Pharmaceutical have expressed their commitment to working together to ensure the success of the partnership.